EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Silico Assessment of SYNGAP1 Missense Variant Pathogenicity

Aliaa E Ali iD, Henna-Riikka M Otranen iD, Jukka V Lehtonen iD, Michael J Courtney iD, Olli T Pentikäinen iD, Pekka A Postila iD

Human Mutation · 2026-01 · 2026 (1)

DOI: 10.1155/humu/8234670 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Mutation, online erschienen am 08.11.2026. Verfasst von Aliaa E Ali und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedicine Integrative Physiology and Pharmacology Faculty of Medicine University of Turku Turku Finland utu.fi. Hauptthemen laut MEDLINE: Mutation, Missense, ras GTPase-Activating Proteins, Computational Biology. Die Arbeit nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Regional Development Fund, Novo Nordisk Fonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SynGAP, a critical regulator at the postsynaptic density, is associated with Alzheimer′s disease, tumorigenesis, and most notably, SYNGAP1 ‐related disorders (SRD), which manifests as autism, epilepsy, and cognitive impairment. SRD is likely primarily caused by SynGAP missense (SGM) variants, whose pathogenicity is difficult to confirm experimentally. To address this issue, a wide range of structure‐ and/or sequence‐based as well as machine learning– and deep learning–based in silico predictors were benchmarked against clinically annotated SRD data. Folding stability calculations (e.g., Foldetta) and deep learning methods ESM1b and AlphaMissense showed the highest prediction accuracy under default settings. Applying optimized nondefault thresholds, especially with AlphaMissense, could further improve predictor performance. The predictions exhibited a strong structural pattern: Pathogenic variants were highly enriched within defined structural domains, particularly the GAP and PH domains, whereas variants located in nondomain and nonmotif regions were predominantly predicted to be benign. The verified phosphosites and predicted phase separation impacting variants occupy matching sections, including the protein′s N‐terminal region and the vicinity of putative SH3‐binding motif in the disordered regions. Thus, these regions collectively could act as phase separation‐promoting segments, complementing the protein′s trimerization‐coupled coiled‐coil domain. Finally, the SynGAP Missense (SGM) server was presented to support SynGAP variant assessment. The SGM server integrates a Data Table with top‐performing predictors, a 3D Viewer for structure‐level assessment and AI‐generated lay summaries for all variants arising from single‐base substitutions, including those not yet observed in public databases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mutation, Missenseras GTPase-Activating ProteinsComputational BiologyHumansComputer SimulationMachine LearningModels, MolecularProtein Conformation

Stichwörter der Autor:innen

SYNGAP1SYNGAP1-related disorders (SRD)SynGAPSynGAP missense (SGM) serverdatabasemissense mutationmissense variantpathogenicity prediction

Substanzen

ras GTPase-Activating ProteinsSYNGAP1 protein, human

Autor:innen und Institutionen

  • Institute of Biomedicine Integrative Physiology and Pharmacology Faculty of Medicine University of Turku Turku Finland utu.fi.
  • InFLAMES Research Flagship University of Turku Turku Finland utu.fi.
  • Structural Bioinformatics Laboratory Department of Natural and Health Sciences Åbo Akademi University Turku Finland abo.fi.
  • InFLAMES Research Flagship Åbo Akademi University Turku Finland abo.fi.
  • Neuronal Signalling Laboratory and Turku Screening Unit Turku Bioscience Centre University of Turku and Åbo Akademi University Turku Finland.
  • Aurlide Ltd. Turku Finland.

ORCID-Profile: Aliaa E Ali, Henna-Riikka M Otranen, Jukka V Lehtonen, Michael J Courtney, Olli T Pentikäinen, Pekka A Postila

Förderung

  • European Regional Development Fund
  • Novo Nordisk Fonden

Zitieren

APA

Ali, A. E., Otranen, H. M., Lehtonen, J. V., Courtney, M. J., Pentikäinen, O. T., & Postila, P. A. (2026). In Silico Assessment of SYNGAP1 Missense Variant Pathogenicity. Human Mutation, 2026(1). https://doi.org/10.1155/humu/8234670

Vancouver

Ali AE, Otranen HM, Lehtonen JV, Courtney MJ, Pentikäinen OT, Postila PA. In Silico Assessment of SYNGAP1 Missense Variant Pathogenicity. Human Mutation. 2026;2026(1). doi:10.1155/humu/8234670

BibTeX
@article{Ali2026,
  author = {Ali, Aliaa E and Otranen, Henna-Riikka M and Lehtonen, Jukka V and Courtney, Michael J and Pentikäinen, Olli T and Postila, Pekka A},
  title = {In Silico Assessment of SYNGAP1 Missense Variant Pathogenicity},
  journal = {Human Mutation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/humu/8234670}
}
Kostenlos starten →